The association between Urinary Albumin Excretion (UAE) and Cardiovascular (CV) risk has been well established. However, it has been not demonstrated whether regression of UAE is associated with reduced CV risk. The aim of the current study was to evaluate the relationship between changes of UAE induced by pharmacologic therapies and CV events. Methods: The MEDLINE, Cochrane, ISI Web of Science and SCOPUS database were searched for articles about UAE until October 2012. Randomized trials assessing UAE at baseline and at the end of follow-up, enrolling more than 200 hypertensive and/or diabetic patients and reporting clinical end-points (all-cause death, Myocardial Infarction (MI), stroke and CV death) were included in the study. Meta-regression analysis was performed to test the relationship between UAE changes and clinical end-points. The influence of baseline patients' characteristics, follow-up, study publication year, Detsky quality score, changes in blood pressure from baseline to the end of follow-up, degree of albuminuria, glomerular filtration rate, comorbidities and concomitant pharmacological treatments were also explored. Egger's method was used to assess publication bias. Results: 32 trials enrolling 80,812 participants were included. In meta-regression analysis, a relationship between UAE changes from baseline to end of follow-up and risk MI (change in Tau2 (t)=2.74; p Tau (p)=0.011), stroke (t=2.35; p=0.030) and CV events (including MI, stroke and CV death) (t=3.74; p=0.001) was found. Results were confirmed by sensitivity analysis. No heterogeneity among studies or publication bias were detected. Conclusions: In diabetic and/or hypertensive patients, a decrease in UAE is associated with reduced risk of MI, stroke and the composite of MI/stroke/CV death. These findings may have implications for monitoring CV risk in clinical practice.
Purpose: Acromegaly (AC) increases the risk of cardiovascular diseases. We evaluated Coronary Flow Reserve (CFR) by Transthoracic Doppler Echocardiography (TDE), as an index of coronary microvascular function, in AC. Methods: 39 AC patients (pts) (22 M, aged 52±11 years) without clinical evidence of heart disease, and 48 controls matched for age and gender were studied. Coronary flow velocity in the left anterior descending coronary artery was detected by TDE at rest and during adenosine infusion. CFR was the ratio of hyperaemic Diastolic Flow Velocity (DFV) to resting DFV. A CFR≤2.5 was considered abnormal. The median time between the onset of symptoms and CFR assessment was 5 years (interquartile range 2-10 years). Results: In AC pts, CFR was lower than in controls (2.9±0.8 vs 3.8±0.7, p<0.0001) ( Figure A) . CFR was ≤2.5 in 13 (33.3%) pts compared with controls (0%) (p<0.0001). CFR was inversely related to insulin-like growth factor 1 (IGF-1) levels ( Figure B ). In pts with CFR≤2.5, IGF-1 was higher (756 [381-898] Purpose: Obese middle-aged men without metabolic disturbances have recently been found to carry the same cardiovascular risk as their normal weight, metabolically healthy counterparts. In this setting we examined the risk of myocardial infarction, ischemic stroke and all-cause mortality in a large population of young fertile women. Methods: From nationwide registers of birth records we identified all Danish women giving birth in the period 2004-2010. Metabolically unhealthy was defined as the presence of either a hypertensive disorder (gestational hypertension, preeclampsia, hypertension), an abnormal glucose metabolism (gestational diabetes, diabetes) or dyslipidemia. Four exposure groups were defined according to metabolic health status and pre-pregnancy body mass index (BMI): Metabolically healthy and a BMI<25 kg/m 2 (1) or a BMI≥25 kg/m 2 (2), metabolically unhealthy and a BMI<25 kg/m 2 (3) or BMI≥25.0 kg/m 2 (4), respectively. Using Poisson regression models adjusted for age and calendar year, the risk of the combined end-point of myocardial infarction, ischemic stroke and all-cause mortality was assessed with (1) as reference.
Results: The population consisted of 273,101 women with a mean age of 31.2 (SD 4.9) years and a median follow up of 5.5 years (IQR 3.8; 6.8). In the normal weight metabolically healthy women (1) the incidence rate (IR) per 1000 person years for the combined endpoint was 0.41 (95% confidence interval [CI] 0.37-0.45, number of events, n=375). For the obese but metabolically healthy women (2) the IR was 0.45 (CI 0.39-0.52, number of events, n=51) and rate ratio (RR) was 1.16 (CI 0.93-1.33). In the normal weight but metabolically unhealthy women (3) the IR was 0.91 (CI 0.69-1.2, number of events, n=175) and RR was 2.11 (CI 1.58-2.83). The IR for the obese and metabolically unhealthy women (4) was 1.25 (CI 1.01-1.54, number of events, n=86) and the RR was 2.81 (CI 2.22-3.56). Conclusions: In a nationwide low risk population of young fertile women being obese but metabolically healthy confers a similar risk of myocardial infarction, stroke and all-cause mortality compared to normal weight, metabolically healthy women, while metabolically unhealthy women had increased risk of MI, stroke and all-cause mortality irrespective of BMI.
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Depression symptoms and the progression of carotid intima-media thickness: a 5-year follow-up study C. Pizzi, L. Santarella, G.M. Costa, R. Bugiardini. University of Bologna, Bologna, Italy Background: Only a few studies have investigated the changes in carotid intimamedia thickness (IMT) over time, and uncertainties remain on the underlying mechanisms linking depression and subclinical atherosclerosis. We carried out a prospective cohort study to evaluate whether depression is associated with changes in carotid IMT in subjects with cardiac risk factors but free from coronary heart disease (CHD), and to what extent the atherogenicity of depression can be explained by inflammatory markers and autonomic nervous system dysfunction. Methods and results: During baseline and follow-up visits: all participants were asked to provide blood samples and compile a structured questionnaire; trained physicians assessed depression symptoms using Beck Depression Inventory (BDI); altered cardiac autonomic tone was measured using time-domain components of heart rate variability in 24h Holter recordings; measurements of carotid IMT were carried out using B-mode ultrasound image acquisition. Logistic and linear regression analyses were used to adjust for potential confounders and explore potential mediators. A total of 381 subjects completed the 5-year followup. The mean carotid IMT significantly increased in all subjects but the amount of increase was significantly larger among subjects with depression symptoms: mean IMT increased by 0.16±0.14 mm; 0.31±0.28 mm and 0.61±0.54 mm among the subjects with no, mild and moderate/severe depression, respectively (all p<0.01). The association between moderate/severe depression and IMT increase remained highly significant even after controlling for all the variables considered, however when both IL-6 and CRP were included in multivariate models the regression coefficient decreased by 42.3%. Some of the inflammation markers and autonomic nervous system dysfunction were also independently correlated with carotid IMT increase. Conclusion: Depression symptoms are independently associated with an accelerated progression of carotid IMT in subjects with CHD risk factors, and inflammation may substantially modulate the association between depression and carotid IMT progression. Downloaded from https://academic.oup.com/eurheartj/article-abstract/34/suppl_1/2660/2861297 by guest on 01 January 2019
